Terms: = Leukemia AND WAS, P42768, 7454, ENSG00000015285, WASP, THC, IMD2 AND Prognosis
4 results:
1. Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia.
Garitano-Trojaola A; Sancho A; Götz R; Eiring P; Walz S; Jetani H; Gil-Pulido J; Da Via MC; Teufel E; Rhodes N; Haertle L; Arellano-Viera E; Tibes R; Rosenwald A; Rasche L; Hudecek M; Sauer M; Groll J; Einsele H; Kraus S; Kortüm MK
Commun Biol; 2021 Jun; 4(1):799. PubMed ID: 34172833
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical features and genotype analysis of 132 patients with Wiskott-Aldrich syndrome].
Li W; Liu D; Zhang X; Ding Y; Zhao X
Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):925-30. PubMed ID: 26887548
[TBL] [Abstract] [Full Text] [Related]
3. [Interaction of WAVE1 and genes involved in multiple drug resistance in children with acute myeloblastic leukemia].
Yang MH; Zhao MY; He YL; Wang MH; Wang Z; Xie M; Wu XS; Cao LZ
Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):175-9. PubMed ID: 20426950
[TBL] [Abstract] [Full Text] [Related]
4. An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types.
Staub E; Groene J; Heinze M; Mennerich D; Roepcke S; Klaman I; Hinzmann B; Castanos-Velez E; Pilarsky C; Mann B; Brümmendorf T; Weber B; Buhr HJ; Rosenthal A
J Mol Med (Berl); 2009 Jun; 87(6):633-44. PubMed ID: 19399471
[TBL] [Abstract] [Full Text] [Related]
